304 related articles for article (PubMed ID: 9428158)
1. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: evaluation of performance in vivo.
Jean-François J; D'Urso EM; Fortier G
Biotechnol Appl Biochem; 1997 Dec; 26(3):203-12. PubMed ID: 9428158
[TBL] [Abstract][Full Text] [Related]
2. Poly(ethylene glycol)-serum albumin hydrogel as matrix for enzyme immobilization: biomedical applications.
D'Urso EM; Jean-François J; Doillon CJ; Fortier G
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(5):587-95. PubMed ID: 8528452
[TBL] [Abstract][Full Text] [Related]
3. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: I: Preparation and in vitro characterization.
Jean-François J; Fortier G
Biotechnol Appl Biochem; 1996 Jun; 23(3):221-6. PubMed ID: 8679108
[TBL] [Abstract][Full Text] [Related]
4. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
Jarrar M; Gaynon PS; Periclou AP; Fu C; Harris RE; Stram D; Altman A; Bostrom B; Breneman J; Steele D; Trigg M; Zipf T; Avramis VI
Pediatr Blood Cancer; 2006 Aug; 47(2):141-6. PubMed ID: 16425271
[TBL] [Abstract][Full Text] [Related]
5. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
[TBL] [Abstract][Full Text] [Related]
6. Asparagine concentration in plasma after 2,500 IU/m(2) PEG-asparaginase i.v. in children with acute lymphoblastic leukemia.
Wenner KA; Vieira Pinheiro JP; Escherich G; Wessalowski R; Jorch N; Wolff J; Stehn M; Kohlschütter A; Boos J; Janka-Schaub GE
Klin Padiatr; 2005; 217(6):321-6. PubMed ID: 16307417
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.
Ballerini A; Moro F; Nerini IF; Marzo CM; Di Clemente A; Ferrari M; D'Incalci M; Biondi A; Colombini A; Conter V; Porcu L; Cervo L; Rizzari C; Zucchetti M
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1267-1271. PubMed ID: 28424964
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
[TBL] [Abstract][Full Text] [Related]
9. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
Aslanian AM; Kilberg MS
Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
[TBL] [Abstract][Full Text] [Related]
10. Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500 IU/m(2) PEG asparaginase in children with ALL treated according to protocol COALL-06-97.
Vieira Pinheiro JP; Wenner K; Escherich G; Lanvers-Kaminsky C; Würthwein G; Janka-Schaub G; Boos J
Pediatr Blood Cancer; 2006 Jan; 46(1):18-25. PubMed ID: 15929133
[TBL] [Abstract][Full Text] [Related]
11. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients.
Armstrong JK; Hempel G; Koling S; Chan LS; Fisher T; Meiselman HJ; Garratty G
Cancer; 2007 Jul; 110(1):103-11. PubMed ID: 17516438
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
[TBL] [Abstract][Full Text] [Related]
13. L-asparaginase immobilization in supramolecular nanogels of PEG-grafted poly HPMA and bis(α-cyclodextrin) to enhance pharmacokinetics and lower enzyme antigenicity.
Monajati M; Tamaddon AM; Abolmaali SS; Yousefi G; Javanmardi S; Borandeh S; Heidari R; Azarpira N; Dinarvand R
Colloids Surf B Biointerfaces; 2023 May; 225():113234. PubMed ID: 36934612
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetic studies of three asparaginase preparations.
Asselin BL; Whitin JC; Coppola DJ; Rupp IP; Sallan SE; Cohen HJ
J Clin Oncol; 1993 Sep; 11(9):1780-6. PubMed ID: 8355045
[TBL] [Abstract][Full Text] [Related]
15. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
16. Superior operational stability of immobilized L-asparaginase over surface-modified carbon nanotubes.
Almeida MR; Cristóvão RO; Barros MA; Nunes JCF; Boaventura RAR; Loureiro JM; Faria JL; Neves MC; Freire MG; Santos-Ebinuma VC; Tavares APM; Silva CG
Sci Rep; 2021 Nov; 11(1):21529. PubMed ID: 34728685
[TBL] [Abstract][Full Text] [Related]
17. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.
Aslanian AM; Fletcher BS; Kilberg MS
Biochem J; 2001 Jul; 357(Pt 1):321-8. PubMed ID: 11415466
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization and immobilization of Erwinia carotovoral-asparaginase in a microplate for high-throughput biosensing of l-asparagine.
Labrou NE; Muharram MM
Enzyme Microb Technol; 2016 Oct; 92():86-93. PubMed ID: 27542748
[TBL] [Abstract][Full Text] [Related]
19. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
[TBL] [Abstract][Full Text] [Related]
20. Levels of L-asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia.
Dibenedetto SP; Di Cataldo A; Ragusa R; Meli C; Lo Nigro L
J Clin Oncol; 1995 Feb; 13(2):339-44. PubMed ID: 7844595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]